Détail du document
Identifiant

doi:10.1186/s41983-021-00358-5...

Auteur
Fahmy, Ebtesam Mohamed Elawady, Mohamed Elsayed Sharaf, Sahar Heneidy, Sarah Ismail, Rania Shehata
Langue
en
Editeur

Springer

Catégorie

Neurology

Année

2021

Date de référencement

08/12/2022

Mots clés
vitamin d receptor (vdr) gene poly... vdr-apai snp and vdr-foki snp gene... idiopathic parkinson disease (pd) parkinson foki disease vdr gene apai
Métrique

Résumé

Background Accumulating data have suggested that vitamin D receptor (VDR) gene is a pretender gene for vulnerability to Parkinson disease (PD).

This study aimed to assess the relationship of VDR gene polymorphisms (FokI and ApaI) with PD.

Fifty patients suffering from PD and 50 age- and sex-matched healthy controls were included.

Unified Parkinson Disease Rating Scale (UPDRS) was done to assess disease severity.

Genetic testing for VDR gene single nucleotide polymorphisms (FokI and ApaI) was done using real time polymerase chain reaction (PCR) technique.

Results Concerning frequency of genes and alleles for vitamin D receptor gene polymorphisms (FokI and ApaI), no statistically significant difference was found between PD patients and controls.

AC genotype was associated with younger age and younger age at onset of disease compared to CC and AA genotypes of ApaI gene polymorphisms.

CC genotype was significantly positively correlated with fatigue and urine incontinence.

VDR gene polymorphisms were not found to be independent predictors for severity of PD after adjustment for possible confounders.

Conclusion VDR gene polymorphisms are related to the clinical manifestations rather than etiology or severity of idiopathic PD.

Fahmy, Ebtesam Mohamed,Elawady, Mohamed Elsayed,Sharaf, Sahar,Heneidy, Sarah,Ismail, Rania Shehata, 2021, Vitamin D receptor gene polymorphisms and idiopathic Parkinson disease: an Egyptian study, Springer

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced